Do OCEAN Results Really Sink Melflufen in Multiple Myeloma?

Peptide-drug conjugate may still offer a lifeline to subset of HSCT-naive...

Related Keywords

Norway ,United States ,Minnesota ,Boston ,Massachusetts ,Oslo ,Mayo Clinic In Rochester ,Dana Farber Cancer Institute ,America ,American ,Shalmali Pal ,Wilsoni Gonsalves ,Fredrikh Schjesvold ,Paul Richardson ,Bristol Myers Squibb ,Prashant Kapoor ,Pieter Sonneveld ,Amgen ,American Society Of Clinical Oncology ,European Hematology Association ,Novartis ,International Myeloma Workshop ,Kaiser Health News ,Erasmus Mc Cancer Institute In Rotterdam ,European Medicines Agency ,Oslo University Hospital ,Hematology Association ,Myeloma Hub ,Myeloma Workshop ,Mayo Clinic ,North America ,Clinical Oncology ,Conditional Marketing Authorization ,Contributing Writer ,